A detailed history of Steph & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Steph & CO holds 11,753 shares of BMY stock, worth $673,799. This represents 0.22% of its overall portfolio holdings.

Number of Shares
11,753
Previous 11,491 2.28%
Holding current value
$673,799
Previous $477,000 27.46%
% of portfolio
0.22%
Previous 0.19%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$39.66 - $51.75 $10,390 - $13,558
262 Added 2.28%
11,753 $608,000
Q2 2024

Jul 30, 2024

BUY
$40.25 - $52.99 $1,368 - $1,801
34 Added 0.3%
11,491 $477,000
Q1 2024

Apr 12, 2024

BUY
$47.98 - $54.4 $138,134 - $156,617
2,879 Added 33.56%
11,457 $621,000
Q4 2023

Jan 31, 2024

SELL
$48.48 - $57.85 $124,642 - $148,732
-2,571 Reduced 23.06%
8,578 $440,000
Q3 2023

Oct 26, 2023

BUY
$57.89 - $64.73 $18,640 - $20,843
322 Added 2.97%
11,149 $647,000
Q2 2023

Jul 14, 2023

BUY
$63.71 - $70.74 $1,274 - $1,414
20 Added 0.19%
10,827 $692,000
Q1 2023

Apr 18, 2023

BUY
$65.71 - $74.53 $262 - $298
4 Added 0.04%
10,807 $749,000
Q4 2022

Jan 26, 2023

BUY
$68.48 - $81.09 $43,347 - $51,329
633 Added 6.22%
10,803 $777,000
Q3 2022

Oct 11, 2022

BUY
$0.13 - $76.84 $46 - $27,201
354 Added 3.61%
10,170 $723,000
Q2 2022

Jul 13, 2022

BUY
$72.62 - $79.98 $122,292 - $134,686
1,684 Added 20.71%
9,816 $756,000
Q1 2022

Apr 15, 2022

BUY
$61.48 - $73.72 $6,762 - $8,109
110 Added 1.37%
8,132 $594,000
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $2,091 - $2,438
-39 Reduced 0.48%
8,022 $500,000
Q3 2021

Oct 22, 2021

BUY
$59.17 - $69.31 $43,489 - $50,942
735 Added 10.03%
8,061 $477,000
Q2 2021

Jul 27, 2021

BUY
$61.91 - $67.42 $97,879 - $106,591
1,581 Added 27.52%
7,326 $490,000
Q1 2021

Apr 16, 2021

SELL
$59.34 - $66.74 $3,797 - $4,271
-64 Reduced 1.1%
5,745 $363,000
Q4 2020

Jan 29, 2021

BUY
$57.74 - $65.43 $84,589 - $95,854
1,465 Added 33.72%
5,809 $360,000
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $80,402 - $89,096
-1,400 Reduced 24.37%
4,344 $262,000
Q1 2020

Apr 14, 2020

SELL
$46.4 - $67.43 $35,588 - $51,718
-767 Reduced 11.78%
5,744 $320,000
Q4 2019

Feb 24, 2020

BUY
$49.21 - $64.19 $320,406 - $417,941
6,511 New
6,511 $418,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Steph & CO Portfolio

Follow Steph & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.